Eli Avisar
Impact in
- Hepatology top 2%
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 2%
- Cutaneous Melanoma Detection and Management
- Colorectal Cancer Treatments and Studies
- Cancer survivorship and care
- Vascular Tumors and Angiosarcomas
Papers in
- Oncology 32
- Cutaneous Melanoma Detection and Management 11
- Lymphatic System and Diseases 5
- Global Cancer Incidence and Screening 4
-
- Breast Cancer Treatment Studies 26
- Co-authors
- Salomone Di Saverio (2 shared papers)Juan C. Gutierrez (1 shared paper)F Kunstlinger (1 shared paper)Françis Lévi (1 shared paper)René Adam (1 shared paper)D. Castaing (1 shared paper)Arié Ariche (1 shared paper)Daniel Azoulay (1 shared paper)
- Journals
- Annals of Surgical Oncology (11 papers)Breast Cancer Research and Treatment (7 papers)Cancer Research (5 papers)Journal of Clinical Oncology (4 papers)Blood (3 papers)
- Partner nations
- United StatesIsraelSweden
In The Last Decade
Eli Avisar
67 papers receiving 2.2k citations
Eli Avisar's Hit Papers
Peers
Comparison fields: 5 of 103
- Hepatology 353
- Oncology 1.1k
- Cancer Research 433
- Pathology and Forensic Medicine 331
- Dermatology 110
Countries citing papers authored by Eli Avisar
This map shows the geographic impact of Eli Avisar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eli Avisar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eli Avisar more than expected).
Fields of papers citing papers by Eli Avisar
This network shows the impact of papers produced by Eli Avisar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eli Avisar. The network helps show where Eli Avisar may publish in the future.
Co-authors
The 25 scholars most cited alongside Eli Avisar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Five-Year Survival Following Hepatic Resection After Neoadjuvant Therapy for Nonresectable Colorectal [Liver] Metastases Hit paper breakdown → | 2001 | 508 |
| 2 | 2007 | 211 | |
| 3 | 2011 | 188 | |
| 4 | 2013 | 168 | |
| 5 | 2008 | 113 | |
| 6 | 2007 | 98 | |
| 7 | 2013 | 97 | |
| 8 | 2011 | 94 | |
| 9 | 2015 | 85 | |
| 10 | 2006 | 83 | |
| 11 | 2009 | 70 | |
| 12 | 2007 | 50 | |
| 13 | 1998 | 49 | |
| 14 | 2018 | 46 | |
| 15 | 2008 | 43 | |
| 16 | 2001 | 38 | |
| 17 | 2015 | 38 | |
| 18 | 2017 | 22 | |
| 19 | 2015 | 22 | |
| 20 | 2008 | 19 |
About Eli Avisar
Eli Avisar is a scholar working on Oncology, Cancer Research, Surgery, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 75 papers that have together received 2.3k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (26 papers), Cutaneous Melanoma Detection and Management (11 papers), Breast Lesions and Carcinomas (11 papers), Breast Implant and Reconstruction (9 papers), Lymphatic System and Diseases (5 papers), Esophageal Cancer Research and Treatment (4 papers), Global Cancer Incidence and Screening (4 papers) and Cancer and Skin Lesions (4 papers). The work is most often cited by research in Hepatology (353 citations), Oncology (1.1k citations), Cancer Research (433 citations), Pathology and Forensic Medicine (331 citations) and Dermatology (110 citations). Eli Avisar has collaborated with scholars based in United States, Israel and Sweden. Frequent co-authors include Salomone Di Saverio, Juan C. Gutierrez, F Kunstlinger, Françis Lévi, René Adam, D. Castaing, Arié Ariche, Daniel Azoulay, S. Giachetti and Stefan Glück. Their work appears in journals such as Annals of Surgical Oncology, Breast Cancer Research and Treatment, Cancer Research, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.